Predicting Vasculitis Relapse? It's SNOT That Hard
(MedPage Today) -- Scores on a patient-reported sino-nasal symptom questionnaire were associated with subsequent flares of one type of ANCA-associated vasculitis (AAV), researchers said.
Patients with granulomatosis with polyangiitis (GPA) who... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 25, 2024 Category: Rheumatology Source Type: news
Can cardiac PET/CT ‘revolutionize’ heart care?
PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say.
The “hybrid” scan – which combines molecular PET and anatomical CT images – may have its highest potential in visualizing early signs of so-called “perfusion deficits” (regions of obstructed blood flow), said Marcelo Di Carli, MD, a professor of radiology and medicine at Harvard Medical School, in a recent interview with AuntMinnie.com.
“[PET/CT] helps us differentiate a patient who has ches...
Source: AuntMinnie.com Headlines - March 25, 2024 Category: Radiology Authors: Will Morton Tags: Clinical News Subspecialties Molecular Imaging Cardiovascular Radiology Source Type: news
Updated ANCA Vasculitis Guideline Aims to Improve Care Updated ANCA Vasculitis Guideline Aims to Improve Care
The KDIGO updates addressed the " unprecedented pace " of scientific advances, including approval of avacopan as an add-on therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 26, 2024 Category: Consumer Health News Tags: Nephrology Source Type: news
Benralizumab Matches Mepolizumab for Rare Vasculitis
(MedPage Today) -- WASHINGTON -- Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the randomized MANDARA trial showed.
Among 140 patients... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 24, 2024 Category: Allergy & Immunology Source Type: news
PET/MRI may help diagnose fevers of unknown origin
PET/MRI imaging shows promise in diagnosing fevers or inflammation of unknown origin and may have advantages over PET/CT, according to a study published January 3 in the European Journal of Radiology.In a study that included 104 patients, PET/MRI provided high sensitivity and specificity for determining underlying causes, especially in patients with elevated C-reactive protein, a blood biomarker of inflammation, according to lead author Tomas Rohan, MD, of University Hospital Brno in Brno, Czechia.“To make the indications more specific to and improve the overall diagnostic performance, F-18 FDG-PET/MRI should be indicate...
Source: AuntMinnie.com Headlines - January 8, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news
When's Best to Re-dose Rituximab After Vasculitis Remission? When's Best to Re-dose Rituximab After Vasculitis Remission?
A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2023 Category: Consumer Health News Tags: Rheumatology Source Type: news
Vasculitis Gives Higher Risk for Adverse Pregnancy Outcomes Vasculitis Gives Higher Risk for Adverse Pregnancy Outcomes
This study should help inform our family planning conversations with our vasculitis patients," Lindsay S. Lally, MD, said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Investor Update - October 27, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Media News - October 27, 2023 Category: Pharmaceuticals Source Type: news
Newly Diagnosed ANCA-associated Vasculitis After COVID-19 Newly Diagnosed ANCA-associated Vasculitis After COVID-19
This report describes a case of antineutrophil cytoplasmic antibody-associated vasculitis following COVID-19 infection.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 13, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia
TUESDAY, Oct. 10, 2023 -- In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Conditions such as alopecia (hair loss), psoriasis, vitiligo (white skin patches), vasculitis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2023 Category: General Medicine Source Type: news
COVID-19 Tied to Autoimmune Disease Risk COVID-19 Tied to Autoimmune Disease Risk
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several other autoimmune conditions.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 6, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Benralizumab Hits Mark in Head-to-Head EGPA Vasculitis Trial Benralizumab Hits Mark in Head-to-Head EGPA Vasculitis Trial
In the study, adults with EGPA were randomized to a single 30-mg subcutaneous injection of benralizumab or three separate 100-mg subcutaneous injections of mepolizumab once every 4 weeks.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
High Risk of Stroke in ANCA-associated Vasculitis High Risk of Stroke in ANCA-associated Vasculitis
A new study finds a higher incidence of stroke among patients with ANCA-associated vasculitis. What are the predictive factors and outcomes of these patients?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Complications From Geographic Atrophy Drug Fuel Questions Complications From Geographic Atrophy Drug Fuel Questions
An extension study found no cases of occlusive retinal vasculitis after 23,000 injections of pegcetacoplan, but a panel received more reports of the complication and dealt with conflicts of interest.Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - August 7, 2023 Category: Opthalmology Tags: Ophthalmology News Source Type: news
